Testosterone Cypionate Missed-Dose Protocol: What to Do and Why It Matters

How to Handle a Missed Testosterone Cypionate Dose

The core rule is straightforward. If you are on a once-weekly schedule and you miss your injection day, administer the dose as soon as you remember. The cutoff is simple: if your next scheduled injection is fewer than 3 to 4 days away, skip the missed dose entirely and continue with the normal schedule. Do not inject two doses within that compressed window.

The FDA-approved prescribing information for testosterone cypionate (Depo-Testosterone) states that patients who miss a dose should take it as soon as possible unless it is almost time for the next dose, at which point the missed dose should be omitted entirely. [1]

Why the 3-to-4-Day Cutoff Exists

The 8-day half-life of the cypionate ester means serum testosterone falls gradually. After a single 200 mg intramuscular injection, peak serum levels of roughly 1,100 ng/dL are reached at 24 to 48 hours, and the level does not drop below 400 ng/dL until approximately day 10 to 12 in most eugonadal-range patients. [2] Because meaningful hypogonadal symptoms (fatigue, low libido, mood changes) generally require serum testosterone below 300 ng/dL, a 48 to 72-hour delay rarely causes clinically significant symptoms.

Twice-Weekly Protocol Adjustments

Men prescribed 50 mg twice weekly (a schedule that produces steadier peaks and troughs) should use a tighter window. If the missed injection is remembered more than 24 hours before the next scheduled dose, administer it. If it is within 24 hours of the next dose, skip it and continue normally. Twice-weekly schedules are often preferred precisely because smaller individual doses reduce the polycythemia risk associated with large weekly boluses. [3]

The Double-Dose Warning

Stacking two doses is not a neutral shortcut. Supraphysiologic testosterone spikes drive erythropoiesis through erythropoietin-independent pathways, raising hematocrit. The Endocrine Society's 2018 clinical practice guideline recommends withholding therapy and phlebotomy when hematocrit exceeds 54%. [4] A single accidental double-dose is unlikely to push most men past that threshold, but the pattern repeated over several weeks could. Estradiol conversion via aromatase also scales with testosterone concentration, potentially raising estradiol above 42 pg/mL and causing fluid retention or gynecomastia in susceptible men. [5]

How Testosterone Cypionate Works: Mechanism of Action

Testosterone cypionate is testosterone attached to a cypionate (cyclopentylpropionate) ester at the 17-beta hydroxyl position. That single structural change converts a water-soluble hormone into a lipophilic depot that dissolves slowly from the injection site oil.

Once the ester is cleaved by tissue esterases, free testosterone enters the bloodstream and binds to the androgen receptor (AR), a ligand-activated transcription factor encoded by the AR gene on chromosome Xq11-12. [6]

Genomic (Slow) Pathway

The testosterone-AR complex translocates to the nucleus, dimerizes, and binds androgen response elements (AREs) in target gene promoters. This genomic signaling drives transcription of proteins involved in muscle protein synthesis, erythropoiesis, and sebaceous gland activity. The time course is hours to days. The T-Trials (NEJM 2016, N=790) demonstrated that 12 months of testosterone treatment in men 65 years or older with a serum level below 275 ng/dL produced a mean increase of 2.5 percentage points in 6-minute walk distance and a 3.2-point improvement on the sexual activity scale compared to placebo. [7]

Non-Genomic (Fast) Pathway

Within minutes, testosterone also activates membrane-associated androgen receptors and second-messenger cascades including PI3K-Akt and MAPK. These non-genomic signals affect vascular tone, calcium flux in cardiomyocytes, and platelet aggregation. [8] The clinical significance of non-genomic testosterone signaling in TRT patients is still being studied, but the pathway partly explains why some men notice mood changes within 24 to 48 hours of a missed injection before testosterone levels have dropped significantly.

DHT and Estradiol Conversion

Approximately 5 to 7% of circulating testosterone is converted to dihydrotestosterone (DHT) by 5-alpha reductase in skin, prostate, and liver. [9] DHT binds the androgen receptor with roughly 3 to 5 times the affinity of testosterone and drives prostate and scalp effects. A further 0.3% is aromatized to estradiol, which is small in percentage terms but clinically important because estradiol maintains bone mineral density, libido, and cardiovascular protection in men on TRT. [5]

Pharmacokinetics: Why the Cypionate Ester Changes Everything

The cypionate ester extends the apparent half-life of testosterone from roughly 10 to 100 minutes (for unesterified testosterone) to approximately 8 days when delivered intramuscularly in sesame oil. [2]

Absorption and Distribution

After injection into the gluteal or deltoid muscle (or subcutaneous adipose), the oil depot releases the esterified compound slowly. Esterases in the tissue and blood cleave the cypionate chain, liberating free testosterone. Peak serum concentrations after a 200 mg intramuscular dose reach 1,000 to 1,200 ng/dL at approximately 24 to 48 hours. [2] Subcutaneous injection of the same dose produces a lower, flatter peak (roughly 600 to 800 ng/dL) with a similar or slightly longer time to trough. [10]

Trough Levels and Dosing Frequency

On a once-weekly 100 mg schedule, most men maintain troughs above 400 ng/dL. On a once-weekly 200 mg schedule, troughs typically range from 500 to 700 ng/dL before the next injection, but peaks can reach 1,400 ng/dL or above, producing a wide intra-week swing. Twice-weekly dosing of 50 mg flattens that curve substantially, keeping most patients between 500 and 900 ng/dL throughout the week. [3]

What Happens After a Missed Dose

After a missed weekly injection, testosterone follows first-order elimination from its post-peak level. A patient who peaks at 900 ng/dL on day 2 and misses his day-7 injection will have serum testosterone near 450 ng/dL by day 14, based on the 8-day half-life. Most men will not reach the symptomatic hypogonadal range (<300 ng/dL) until day 17 to 21 if they started near normal therapeutic levels. [2] This pharmacokinetic buffer is why a single missed injection almost never requires an urgent same-day makeup dose.

Clinical Evidence Behind Current Dosing Standards

The key evidence shaping how physicians prescribe testosterone cypionate comes from several well-controlled trials and registry studies.

T-Trials (NEJM 2016)

The Testosterone Trials were a coordinated set of seven placebo-controlled trials conducted at 12 U.S. Sites in men 65 years or older with a serum testosterone below 275 ng/dL. The sexual function trial (N=470) showed that men randomized to testosterone gel (titrated to serum levels of 500 to 900 ng/dL) reported significantly higher scores on the Psychosexual Daily Questionnaire sexual desire domain: mean difference 0.58 points, 95% confidence interval 0.39 to 0.78 (P<0.001). [7] The vitality trial and physical function trial showed more modest but statistically significant improvements. These trials used gel rather than cypionate, but the target serum testosterone range (500 to 900 ng/dL) is the same range most TRT prescribers target with weekly cypionate injections.

Endocrine Society 2018 Clinical Practice Guideline

The Endocrine Society's guideline recommends confirming hypogonadism with two morning serum testosterone measurements below the laboratory-specific lower limit of normal (generally below 300 ng/dL) on separate days before initiating therapy. [4] The guideline states directly: "We recommend against testosterone therapy in patients who are planning fertility in the near future." Regarding monitoring, it specifies checking hematocrit at 3 to 6 months post-initiation and annually thereafter, targeting a hematocrit below 54%.

Subcutaneous vs. Intramuscular Injection

A 2012 prospective study (N=37) published in the International Journal of Impotence Research found that subcutaneous testosterone cypionate injections produced therapeutic serum levels with a flatter concentration-time curve and significantly less injection-site pain compared to intramuscular injection. [10] Many prescribers now favor subcutaneous administration for this reason, particularly for patients self-injecting. The missed-dose rules are identical regardless of route.

Monitoring Parameters on Testosterone Cypionate

Dose adjustments and missed-dose decisions should be made against a backdrop of regular laboratory monitoring. The following framework reflects the Endocrine Society 2018 guideline [4] and real-world HealthRX clinical practice.

Baseline Labs Before Starting

• Total testosterone (morning, fasting), two measurements on separate days
• Free testosterone (calculated or equilibrium dialysis)
• LH and FSH (to distinguish primary from secondary hypogonadism)
• Hematocrit and complete blood count
• PSA (men 40 years or older)
• Estradiol (sensitive LC-MS/MS assay preferred)
• Metabolic panel and lipid panel

On-Therapy Monitoring Schedule

At 3 months: total testosterone (drawn as a trough, morning of the next scheduled injection), hematocrit, PSA.

At 6 months: repeat all baseline labs.

Annually thereafter: testosterone trough, hematocrit, PSA, lipid panel.

Testosterone target on once-weekly cypionate: trough 400 to 700 ng/dL (measured just before the next injection). Peak-to-trough swing wider than 600 ng/dL often indicates that splitting to twice-weekly dosing would improve symptom stability.

Hematocrit Management

Hematocrit above 50% warrants dose reduction or switch to a more frequent, lower-dose schedule. Above 54%, the Endocrine Society recommends stopping therapy temporarily and performing phlebotomy. [4] Patients who miss doses frequently may paradoxically benefit from that lower average exposure if hematocrit has been trending upward.

Special Populations and the Missed-Dose Protocol

Older Men (65+)

The T-Trials cohort (mean age 72) showed that older men respond to testosterone with a meaningful increase in erythropoiesis: hematocrit rose above 54% in 5.9% of the testosterone group vs. 0.8% of placebo (P<0.001). [7] For this reason, older men who miss a dose should not double-dose under any circumstances. A missed injection in this group is sometimes a clinical opportunity rather than a problem.

Men on Fertility-Sparing Protocols

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis. LH and FSH typically fall to undetectable levels within 4 to 6 weeks of starting testosterone cypionate, stopping intratesticular testosterone production and impairing spermatogenesis. [11] Men who are attempting to conceive should not be on testosterone cypionate at all. If a man on TRT wishes to restore fertility, human chorionic gonadotropin (hCG) 500 to 1,000 IU subcutaneously three times weekly is typically added or testosterone is stopped in favor of clomiphene or hCG monotherapy. [4]

Women Prescribed Testosterone Cypionate Off-Label

Testosterone cypionate is occasionally used off-label in women for hypoactive sexual desire disorder (HSDD) at doses of 1.5 to 6 mg per week intramuscularly or subcutaneously. The FDA has not approved testosterone for women. [12] The missed-dose window for women is narrower due to lower target serum levels (15 to 70 ng/dL for total testosterone): if more than 3 days late on a weekly schedule, the prescriber should be contacted before re-dosing to avoid supraphysiologic peaks. Virilization (clitoral enlargement, voice deepening, acne) is dose-dependent and concentration-driven.

Step-by-Step Missed-Dose Decision Guide

The algorithm below applies to testosterone cypionate on standard TRT schedules.

Once-weekly schedule (e.g., every Monday):

1. Missed dose noticed same day or 1 to 2 days late. Inject immediately. Keep the next injection on the original scheduled day.
2. Missed dose noticed 3 days late (halfway through the week). Inject immediately. Shift the next injection 3 days later to maintain spacing, then return to the original schedule the following week.
3. Missed dose noticed 4 to 5 days late (next injection is 2 to 3 days away). Skip the missed dose. Inject on the normal scheduled day.
4. Missed dose noticed 6 to 7 days late (next injection is tomorrow or today). Skip the missed dose. Inject on the normal scheduled day only.

Twice-weekly schedule (e.g., Monday and Thursday):

1. Missed dose noticed less than 24 hours before the next scheduled injection. Skip the missed dose and inject on the scheduled day.
2. Missed dose noticed more than 24 hours before the next scheduled injection. Inject immediately and resume the normal twice-weekly schedule.

If you are uncertain, draw a serum testosterone level. A result above 400 ng/dL at the time you noticed the miss means there is no clinical urgency to administer a makeup injection before the next scheduled dose.

FAQ